HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M A Jacobson Selected Research

BW A1433

10/2001Targeted deletion of A(3) adenosine receptors improves tolerance to ischemia-reperfusion injury in mouse myocardium.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M A Jacobson Research Topics

Disease

4Acquired Immunodeficiency Syndrome (AIDS)
05/2009 - 01/2000
2Retinitis
05/2005 - 05/2001
2HIV Infections (HIV Infection)
11/2001 - 11/2000
2Reperfusion Injury
10/2001 - 04/2001
1Viremia
05/2009
1Uveitis
05/2005
1Pain (Aches)
01/2002
1Hyperalgesia
01/2002
1Edema (Dropsy)
01/2002
1Inflammation (Inflammations)
01/2002
1Ischemia
10/2001
1Myocardial Ischemia (Ischemic Heart Diseases)
04/2001
1Pneumonia (Pneumonitis)
02/2001
1Chronic Hepatitis B
11/2000
1Infections
11/2000
1Cytomegalovirus Retinitis
01/2000

Drug/Important Bio-Agent (IBA)

2Purinergic P1 Receptors (Adenosine Receptor)IBA
10/2001 - 04/2001
1ValganciclovirFDA Link
05/2009
1Adenosine A3 ReceptorIBA
01/2002
1CarrageenanIBA
01/2002
1Clarithromycin (Biaxin)FDA LinkGeneric
11/2001
1MacrolidesIBA
11/2001
1Azithromycin (Zithromax)FDA LinkGeneric
11/2001
1Purinergic P1 Receptor AntagonistsIBA
10/2001
1BW A1433IBA
10/2001
1Itraconazole (Sporanox)FDA LinkGeneric
02/2001
1Pharmaceutical PreparationsIBA
11/2000

Therapy/Procedure

5Highly Active Antiretroviral Therapy (HAART)
05/2009 - 01/2000
3Therapeutics
05/2005 - 11/2000